Loss of heterozygosity on chromosome 9 and loss of chromosome 9 copy number are separate events in the pathogenesis of transitional cell carcinoma of the bladder

International Journal of Cancer

Volumn 75, Issue 1, 1998, Pages 9-14

  Van Tilborg, Angela A G ^a   Hekman, Arnold C P ^a   Vissers, Kees J ^a   Van der Kwast, Theo H ^a   Zwarthoff, Ellen C ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CHROMOSOME 6; CHROMOSOME 9; GENE LOCATION; GENE REPRESSION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; PLOIDY; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, TRANSITIONAL CELL; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; HUMANS; IN SITU HYBRIDIZATION; LOSS OF HETEROZYGOSITY; MONOSOMY; POLYMERASE CHAIN REACTION; URINARY BLADDER NEOPLASMS;

EID: 0032484559     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980105)75:1<9::AID-IJC2>3.0.CO;2-1     Document Type: Article

References (18)

1. CAIRNS, P., Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature (Genet.) 11, 210-212 (1995).
2. CAIRNS, P., SHAW, M.E. and KNOWLES, M.A., Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene, 8, 1083-1085 (1993).
3. HABUCHI, T., DEVLIN, J., ELDER, P.A. and KNOWLES, M.A., Detailed deletion mapping of chromosome 9q in bladder cancer: evidence for two tumour suppressor loci. Oncogene, 11, 1671-1674 (1995).
4. HEDLEY, D.W., FRIEDLANDER, M.L., TAYLOR, I.W., RUGG, C.A. and MUSGROVE, E.A., Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J. Histochem. Cytochem., 31, 1333-1335 (1983).
5. HOPMAN, A.H.M., MOESKER, O., SMEETS, A.W.G.B., PAUWFLS, R.P.E., VOOUS, G.P. and RAMAEKERS, F.C.S., Numerical chromosome 1, 7, 9, and 11 aberrations in bladder cancer detected by in situ hybridization. Cancer Res., 51, 644-651 (1991).
6. JABS, E.W., WOLF, S.F. and MIGEON, B.R., Characterization of a cloned DNA sequence that is present at centromeres of all human autosomes and the X chromosome and shows polymorphic variation. Proc . nat. Sci. (Wash.), 81, 4884-4888 (1984).
7. KALLIONIEMI, A., KALLIONIESMI, O.P., CHRO, G., SAUTER, G., DE VRIES, S., KERSCHMANN, R., CAROLL, P. and WALDMAN, F., Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer, 12, 213-219 (1995).
8. KEEN, A.J. and KNOWLES, M.A., Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene, 9, 2083-2088 (1994).
9. KERSTENS, H.M.J., PODDIGHE, P.J. and HANSELAAR, A.G.J.M., A novel in situ hybridization signal amplification method based on the deposition of biotinylated tyramine. J. Histochem. Cytochem., 43, 347-352 (1995).
10. KNOWES, M.A., ELDER, P.A., WILLIAMSON, M., CAIRNS, J.P., SHAW, M.E. and LAW, M.G., Allelotype of human bladder cancer. Cancer Res., 54, 531-538 (1994).
11. LEKANNE DEPREZ, R.H., RIEGMAN, P.H., VAN DRUNEN, E., WARRINGA, U.L., GROEN, N.A., STEFANKO, S.Z., KOPER, J.W., AVEZAAT, C.J., MULDER, P.G., ZWARTHOFF, E.C. and HAGEMEIJER, A., Cytogenetic, molecular genetic and pathological analyses in 126 meningiomas. J. Neuropathol. exp. Neurol., 54, 224-235 (1995).
12. MOYZIS, R.K., ALBRIGHT, K.L., BARTHOLDI, M.F:., CRAM, L.S., DEAVES, L.,L., HILDEBRAND, C.E., JOSTE, N.E., LONGMIRE, J.L., MEYNE, J. and SCHWARZACHER-ROBINSON, T., Human chromosome-specific repetitive DNA sequences: novel markers for genetic analysis. Chromosoma (Berlin). 95, 375, 386 (1987).
13. ORLOW, I., LACOMBE, L., HANNON, G.J., SERRANO, M., PFLITCER, I., DALBAGNI, G., REUTER, V.E., ZHANG, Z.E., BEACH, D. and CORDON-CARDO, C., Deletion of the p16 and p15 genes in human bladder tumors. J. nat. Cancer Instit. 87, 1524-1529 (1995).
14. PODDIGHE,P.J., BRINGUIER, P.P., VALLINGA, M., SCHALKEN, J.A., RAMAEKERS, F.C. and HOPMAN, A.H., Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J. Pathol., 179, 169-176 (1996).
15. SAUTER, G., MOCH, H., CARROLL, P., KERSCHMANN, R., MIHATSCH, M.J. and WALDMAN, F.M., Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer. Int. J. Cancer, 64, 99-103 (1995).
16. VAN DEKKER, H., BOSMAN, E.T., TEIJGEMAM, R., VISSERS, C.J., TENSTEEG, T.A., KERSTENS, H.M.J., VOONS, G.P. and VERHOFSTAD, A.A.J., Identification of numerical chromosome aberrations in archival tumours by in situ hybridization to routine paraffin sections: evaluation of 23 phaeochromocytomas. J. Pathol., 171, 161-171 (1993).
17. VOORTER, C., JOOS, S., VALLINGA, M., BRINGUIER, P.P., PODDIGHE, P., SCHALKEN, J., DU MANOIR, S., RAMAEKERS, F., LICHTER, P. and HOPMAN, A., Detection ot chromosomal imbalances in transitional cell carcinoma of the bladder by comparative genomic hybridization. Amer. J. Pathol., 146, 1341-1354 (1945).
18. WHEELESS, L.L., REEDER, J.E., HAN, R., MJ. O.C., FRANK, I.N., COCKETI, A.T. and HOPMAN, A.H., Bladder irrigation specimens assayed by fluorescence in situ hybridization to interphase nuclei. Cytometry, 17, 319-326 (1994).